lipid-lowering properties. High levels of consumption of these fatty acids leads to a replacement of arachidonic acid in the membrane phospholipids of diverse cell types and a modulation ofthe production of eicosanoids including prostaglandins, prostacyclins, thromboxanes and leukotrienes. Earlier work had suggested potent effects of these fatty acids on platelets in vitro. However consumption of these fatty acids had more modest effects on platelets, but they may still be of value in the treatment ofthrombogenic disorders.
Maxepa in doses of 10-15 g per day is particularly effective in lowering plasma triglyceride concentrations. At this intake, plasma cholesterol concentrations are not changed significantly. However, the potent triglyceride lowering properties may be of considerable significance when treating conditions wherecardiovascular disease is exacerbated by high concentrations of the triglyceride-rich lipoproteins (VLDL and IDL).
The meeting was well attended indicating the growing interest in this area of research. It is clear that much more can be learned about the interactions of lipids with soluble coagulation factors, platelets and the endothelium.
K R Bruckdorfer
Editorial Representative Forum on Lipids in Clinical Medicine (Accepted 27 November 1987) Report of meeting of Section of Measurement in Medicine, 14-15 September 1987 Bile acids in health and disease: update on cholesterol gallstones and bile acid diarrhoea Keywords: bile acids; diarrhoea; cholesterol gallstones; SeHCAT test; malabsorption A glittering array of international experts was assembled to consider the present state of the art in the field of bile acids.
Professor Alan Hofmann delivered the first contribution, the Burroughs Wellcome Lecture on the cholehepatic and enterohepatic circulations of bile acids. The theme of a postulated circulation of bile acids from the bile ducts directly back to the liver parenchyma was convincingly argued to explain the striking non-bile-acid-dependent choleretic effect of unconjugated bile acids. A highlight of this presentation was the information that the manatee produced an unusual pattern ofbile acids, perhaps not surprising in that this sea-cow lives on an exclusive diet of waterlilies and its own faeces. Illustrations were offered to explain the concept that conjugation ofbile acids largely inhibits passivejejunal absorption, while promoting ileal conservation by the active transport mechanism.
A section of the meeting was devoted to the physiology of bile secretion. Professor S Erlinger beautifully illustrated the mechanism of passage of bile acids through the parenchymal cell in association with transport protein, and entry into the Golgi apparatus prior to secretion at the canuliculus. Dr R Coleman explained that at the canuliculus the bile acids were joined by phospholipid and cholesterol which had been secreted across the cell membrane as vesicles.
Our concepts ofbiliary lipid chemistry have become very much more sophisticated over the years. The simple display of lipid cholesterol and bile acids on triangular co-ordinates to express true cholesterol solubility in mixed micelles ofbile acid and phospholipids has always been an over-simplification, in that the water component of the system is crucial and the conventional diagram offered postulates 90% water content. True cholesterol solubility is influenced by different content of solids and in addition some cholesterol is carried either in the metastable liquid crystals (partially disorderly arrays of cholesterol and phospholipids). A more recent development is the concept of vesicular secretion of phospholipid and cholesterol in bile. These vesicles dynamically associate with bile acids in bile to form micellar aggregates, and clearly the time after initial secretion of bile is crucial in defining its chemical constitution. The meeting was privileged to have Dr M Carey, the world expert in this field, to guide it through this important but biochemically labile area.
A discussion of the pathophysiology of bile and the mechanism of gallstone formation followed. The crucial biochemical defect remains controversial, but may be very largely explained by the over-activity of hepatic HMG co-enzyme A reductase, which is ratelimiting for cholesterol synthesis. Whether there is a true pathogenetic role for reduced activity of cholesterol 7 alpha-hydroxylase and hence effective bile acid synthesis seems -doubtful currently.
Dr K Einar8son discussed various conditions known to be associated with cholesterol gallstone formation which are linked to enhanced cholesterol content of bile and increased cholesterol secretion, such as advancing age, obesity and treatment with fibric acid derivatives.
Physiochemical defects in bile were discussed at length by Dr T Holzbach. Modern concepts of nucleation timethe length of time which cholesterol crystals take to appear in bilewere described at length. Concentration has a role to play here: nucleation is delayed in biles more dilute than 10 g of solids/dl, but this may not be relevant to gallbladder bile. Part ofthe process of nucleation appears to relate to the aggregation of lipid vesicles, and this seems to be promoted by glycoprotein and inhibited by the lipid apoproteins in bile.
Recent studies of gallbladder motor function were discussed by Drs A Lanzini and I Forgacs. The concept of the gallbladder acting as a passive receptacle for bile, which it then squirts out in vigorous contractions when a meal is eaten, is known to be erroneous; and there is continuous filling and emptying even duringfasting. There are abnormalities of gallbladder contraction in gallstone patients, but whether these are the cause or a consequence is not yet clear. However, they must have relevance for the 0141-0768/88/ 050301-02/$02.00/0 © 1988 The Royal Society of Medicine enterohepatic circulation and the size ofthe bile acid pool in gallstone disease.
A session was devoted to gallstone prevention and non-surgical treatment, fields in which there have been some recent advances. Dr K Heaton reviewed the epidemiological evidence on the variation of gallbladder disease. Much ofthis may be old news, but fascinating new evidence is coming from Italy on the variation in the proportions of subjects declaring themselves to have gallbladder disease in questionnaires. This may say more about the perception of health than the pattern of cholelithiasis! Dr Heaton suggested that good ways of avoiding gallstones were keeping slim, making sure to eat breakfast, drinking moderate quantities of alcohol, avoiding constipation and possibly adopting a vegetarian lifestyle. Dr K Hood discussed the vexed territory of post-dissolution recurrence of gallstones. About 30-50% of patients will get their stones back once they have been dissolved, though about 50% of the dissolved stones never seem to recur. Different trials have suggested that some manoeuvres may be protective, but we still do not have any unequivocally uniformly effective method of stopping recurrence.
Professors L Barbara and M Podda discussed modern gallstone dissolution therapy with bile acids. Professor Barbara identified that about 38% of all subjects with gallstones can be considered suitable for an attempt at dissolution therapy. He proposed that ursodeoxycholic acid as monotherapy was the best option, with an efficacy of 35-40% and no side-effects apart from gallstone calcification. Induced calcification may prevent dissolution of stones but does seem to correlate strongly with age, so that it may not affect younger patients. He reported that continuous treatment after dissolution with ursodeoxycholic acid (300 mg daily) did seem to diminish recurrences, but older patients who had had multiple stones seemed to be at particularly high risk of reformation of stones. Professor Podda has studied a combination of ursodeoxycholic acid and chenodeoxycholic acid, given in an attempt to reduce the cost of treatment and diminish the incidence of calcification. While reporting apparently superior success rates, many of the subjects treated were young asymptomatic females with a high proportion offloating stones, who had been detected during an ultrasonography survey of the ostensibly healthy population.
A new direction in the management of gallstones was described by Professors J Thistle and S Zakko who have been installing catheters using percutaneous gallbladder puncture, through which the powerful cholesterol solvent methyl-tert-butyl ether (MTBE) can be instilled. With frequent injection and aspiration of small volumes most gallbladder stones can be dissolved. In a trial of 60 patients, solitary stones disappeared in about 7 h, but multiple stones could take two to three days. Because of the necessary technique of exchange infusion into the gallbladder, automatic pumps are being devised to make this interesting procedure generally practicable. The chemical used is not without toxicity and it is important not to allow it to escape from the gallbladder.
For large stones it is possible to use extra-corporeal shock-wave lithotripsy (ESWL) to produce small fragments which may be more rapidly dissolved. Professor G Paumgartner reviewed the role of ESWL. In his series of 200 patients at Munich using an average of 1200 discharges in 46 m (and with adjuvant bile acid dissolution therapy) it was possible to rid many patients of their gallbladder or bile duct stones. Biliary colic or other abdominal pain may be expected in about one-third of subjects. Both MTBE and ESWL appear to offer simple rapid alternatives to cholecystecomy and bile acid dissolution therapy, and their assessment in the overall management of gallstone disease is eagerly awaited.
A further session was devoted to fat digestion and solubilization and bile acid absorption. A central part of this was a debate on the diagnostic usefulness of the 75 SeHCAT test. This is selenium-labelled homocholic acid-taurine conjugate, which is a cholic acid analogue and only absorbed by active transport in the terminal ileum. It has been used as a test of bile acid malabsorption, though its overall place in diagnostic work-up is still debatable. It had originally appeared to be a very simple test: if less than 15% of administered radioactivity could be detected by whole body scanning 5-7 days after administration of 75 SeHCAT, bile acid malabsorption was considered to be present. Dr R Ferraris suggested that selectingthe gallbladder as an area of interest and only scanning this region might improve results. Dr Riadh Jazrawi illustrated that faecal retention could be a problem in analysis, and that this could be corrected by using a radiochromic-chloride label. The indications and usefulness for these procedures in clinical practice remain to be determined.
In conclusion Professor Alan Hofmann summarized the achievements of bile acid research, the present position and the future prospects. It may be that surgeons can take life a little easier as MTBE and ESWL establish themselves, but it seems likely that gallstone disease will be for bile acid researchers a joy forever. (Accepted 2 November 1987) 
Malcolm C Bateson

